AME

Business profile & competitive position

AMETEK, Inc. (AME) is classified in the Industrials sector, Electrical Equipment & Parts industry. It manufactures electronic instruments and electromechanical devices through two operating groups. Electronic Instruments (EIG) designs and produces advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets. Electromechanical (EMG) supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets.

The financial signatures are consistent with a durable industrial compounder. The net margin is 20.0%, meaning roughly $0.20 of every revenue dollar reaches the bottom line. Return on equity is 14.5%, indicating efficient use of shareholder capital, and the beta is 0.96, so the stock historically tracks the broad market rather than behaving like a deep cyclical. In 2025, AMETEK reported sales of $7,401.1 million, up 6.6%, alongside record operating income, net income, orders and backlog. Those figures point to pricing power and disciplined execution across a diversified set of end markets.

Financial posture

AME carries a $56.7 billion market capitalization and trades at a trailing P/E of 36.0. That multiple prices in above-average growth and margin stability; it also demands consistent execution. The 20.0% net margin and 14.5% ROE provide fundamental support for the premium, while the 0.96 beta suggests lower relative volatility than a highly cyclical industrial.

In 2025, diluted EPS was $6.40, up 7.9%, and the company deployed $933.2 million in cash—net of cash acquired—on acquisitions, specifically Kern and FARO Technologies. The posture, then, is one of a profitable, acquisitive operator trading at a valuation that assumes continued compounding.

Strategic priorities & outlook

AMETEK’s most recent 10-K frames its strategy around the AMETEK Growth Model. The targets are high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Management pairs those goals with Operational Excellence initiatives that include lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions are the second pillar. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. The 2025 deals alone—Kern, focused on high-precision machining and optical inspection, and FARO Technologies, focused on 3D measurement and imaging—cost $933.2 million in cash, net of cash acquired, and extend the company’s presence in precision measurement and automation.

Global expansion is the third leg. AMETEK maintains best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, supporting customer proximity and international growth. In 2025, 52% of EIG’s net sales and 42% of EMG’s net sales were to customers outside the United States. The company employed approximately 22,500 people as of December 31, 2025. The 10-K notes that 2025 produced record operating income, net income, orders and backlog, giving management a solid base for pursuing these priorities.

Macro & geopolitical exposure

As an Electrical Equipment & Parts company serving aerospace, defense, medical, automation and power markets, AMETEK inherits several macro sensitivities. The industry is exposed to industrial capital spending cycles, commodity prices for metals and semiconductors, and component availability. Currency translation matters because roughly half of revenue is generated outside the U.S.; a stronger dollar tends to compress reported results, while a weaker dollar can expand them.

Trade policy and regulation are also relevant. Tariffs or export controls on aerospace, defense or medical components can affect both input costs and customer demand. Products sold into medical, aerospace and power markets face certification, safety and environmental requirements. Geographically, manufacturing footprints in China, Czechia, Malaysia, Mexico and Serbia introduce country-specific operating risks—currency, labor, tax and tariff dynamics—that are inherent to a global industrial supply chain.

Recent developments

On October 15, 2026, AMETEK announced details for its third-quarter 2026 earnings call and webcasted investor conference, according to PR Newswire. The report is scheduled for November 3, 2026 before the market open, with the consensus EPS estimate at $2.11. Two institutional filings highlight buying activity ahead of the report: on October 15, 2026, defenseworld.net reported that Krilogy Financial LLC purchased AME shares, and on October 9, 2026, the same source noted that GAMMA Investing LLC had also bought the stock. Neither filing discloses the investment rationale.

Also on October 15, 2026, zacks.com published a headline asking whether AMETEK was outperforming other Computer and Technology stocks this year. That classification differs from AMETEK’s Industrials/Electrical Equipment & Parts grouping, reflecting how various data providers segment the stock rather than a change in the underlying business.

Earnings behavior & post-earnings drift

AME’s earnings consistency is striking. Over the last eight reported quarters, the company beat the consensus EPS estimate in every quarter—an 8/8, or 100%, beat rate—with an average earnings surprise of 4%. Yet the market has largely priced in those beats immediately. The average five-day price move following earnings across those quarters is 0.46%, classified as a flat drift.

The last four reports show how quickly surprises are absorbed. On August 4, 2026, AMETEK reported $2.09 versus a $1.99 estimate, a 5.0% surprise; the stock rose 0.28% the next day and 0.89% over the following five sessions. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, $2.01 versus $1.94 (3.6% surprise) produced a -0.48% next-day move but a 1.83% gain over five days. The October 30, 2025 report delivered $1.89 versus $1.76 (7.4% surprise), with a 1.91% next-day advance and a -0.54% five-day drift. Heading into the November 3, 2026 report, the market may be applying an upward adjustment around the $2.11 official consensus simply because AME has beaten in every recent quarter.